Published in Gene Therapy Weekly, August 7th, 2008
"The current study assessed the consequences of two separate, naturally occurring MYH9 dominant mutant alleles, MYH9(R702C) and MyH9(R705H) linked to syndromic and nonsyndromic hearing loss, respectively, upon diverse NNMC-IIA related...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.